Sachiyo Minegishi

Sachiyo Minegishi currently serves as Chief Operating Officer at Rectify Pharma since April 2023. Previously, Minegishi held prominent positions including Chief Financial Officer at Akouos from October 2020 to February 2023, and Vice President with a focus on Sickle Cell Disease at bluebird bio from April 2016 to September 2020. Additional experience includes leadership roles in marketing and business development at Aegerion Pharmaceuticals, Human Genome Sciences, and Genzyme. Minegishi's career began in health care investment banking at Merrill Lynch and transitioned into marketing and product management at Amgen. Educational qualifications include a BS in Chemical Engineering and Economics from the Massachusetts Institute of Technology, and an MBA in Health Care Management from The Wharton School.